Home > Insider Trading > Filing (0001104659-24-108702)

Filing Details

Accession Number:: 0001104659-24-108702
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-10-15 17:48:17
Reporting Period:: 2024-10-15

Accepted Time:: 2024-10-15 17:48:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1736730	Camp4 Therapeutics Corp	CAMP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1598549	J. Andrew Schwab	C/O Camp4 Therapeutics Corporation One Kendall Sq., Bldg 1400 West, 3Rd Fl. Cambridge MA 02139		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-10-15	1,337,592	$0.00	1,337,592	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2024-10-15	378,463	$0.00	1,716,055	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2024-10-15	302,770	$0.00	302,770	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2024-10-15	909,090	$11.00	2,625,145	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Prime Preferred Stock	Disposition	2024-10-15	15,002,166	$0.00	1,337,592	$0.00
Common Stock	Series B Preferred Stock	Disposition	2024-10-15	4,244,770	$0.00	378,463	$0.00
Common Stock	Series B Preferred Stock	Disposition	2024-10-15	3,395,816	$0.00	302,770	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

On October 15, 2024, the shares of Series A Prime Convertible Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering. The Series A Convertible Preferred Stock had no expiration date.
The reported securities are held directly by 5AM Ventures VI, L.P. ("5AM Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of 5AM Ventures VI. The Reporting Person is a managing member of Partners VI and may be deemed to share voting and investment power over the shares held by 5AM Ventures VI. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
On October 15, 2024, the shares of Series B Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date.
The reported securities are held by 5AM Opportunities II, L.P. ("5AM Opportunities"). 5AM Opportunities II (GP), LLC ("Opportunities II GP") is the sole general partner of 5AM Opportunities. The Reporting Person is a managing member of Opportunities II GP and may be deemed to share voting and investment power over the shares held by 5AM Opportunities. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.